Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3609-18. doi: 10.1073/pnas.1507704112. Epub 2015 Jun 22.

Abstract

Adenosine A2A receptor (A2AR)-dopamine D2 receptor (D2R) heteromers are key modulators of striatal neuronal function. It has been suggested that the psychostimulant effects of caffeine depend on its ability to block an allosteric modulation within the A2AR-D2R heteromer, by which adenosine decreases the affinity and intrinsic efficacy of dopamine at the D2R. We describe novel unsuspected allosteric mechanisms within the heteromer by which not only A2AR agonists, but also A2AR antagonists, decrease the affinity and intrinsic efficacy of D2R agonists and the affinity of D2R antagonists. Strikingly, these allosteric modulations disappear on agonist and antagonist coadministration. This can be explained by a model that considers A2AR-D2R heteromers as heterotetramers, constituted by A2AR and D2R homodimers, as demonstrated by experiments with bioluminescence resonance energy transfer and bimolecular fluorescence and bioluminescence complementation. As predicted by the model, high concentrations of A2AR antagonists behaved as A2AR agonists and decreased D2R function in the brain.

Keywords: GPCR heteromers; adenosine A2A receptor; caffeine; dopamine D2 receptor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine A2 Receptor Agonists / metabolism
  • Adenosine A2 Receptor Agonists / pharmacology
  • Adenosine A2 Receptor Antagonists / metabolism
  • Adenosine A2 Receptor Antagonists / pharmacology
  • Animals
  • Binding, Competitive / drug effects
  • Bioluminescence Resonance Energy Transfer Techniques
  • CHO Cells
  • Corpus Striatum / metabolism*
  • Cricetinae
  • Cricetulus
  • Dopamine Agonists / metabolism
  • Dopamine Agonists / pharmacology
  • Dopamine D2 Receptor Antagonists / metabolism
  • Dopamine D2 Receptor Antagonists / pharmacology
  • Dose-Response Relationship, Drug
  • HEK293 Cells
  • Humans
  • Kinetics
  • Male
  • Microscopy, Confocal
  • Protein Binding / drug effects
  • Protein Multimerization*
  • Rats, Sprague-Dawley
  • Receptor, Adenosine A2A / chemistry
  • Receptor, Adenosine A2A / metabolism*
  • Receptors, Dopamine D2 / chemistry
  • Receptors, Dopamine D2 / metabolism*
  • Sheep
  • Time Factors

Substances

  • Adenosine A2 Receptor Agonists
  • Adenosine A2 Receptor Antagonists
  • Dopamine Agonists
  • Dopamine D2 Receptor Antagonists
  • Receptor, Adenosine A2A
  • Receptors, Dopamine D2